Keros Therapeutics, Inc. (KROS)

NASDAQ: KROS · Real-Time Price · USD

17.48

-0.02 (-0.11%)

At close: Nov 28, 2025, 1:00 PM EST

17.52

+0.04 (0.23%)

After-hours: Nov 28, 2025, 4:17 PM EST

Keros Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2018 - 2019
Period Ending	Nov '25 Nov 28, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2018 - 2019
Market Capitalization	533	641	1,191	1,323	1,369	1,635	Upgrade
Market Cap Growth	-80.71%	-46.17%	-9.94%	-3.39%	-16.27%	-	Upgrade
Enterprise Value	-143	130	918	1,084	1,149	1,502	Upgrade
Last Close Price	17.48	15.83	39.76	48.02	58.51	70.54	Upgrade
PS Ratio	2.87	180.63	7888.64	-	68.11	-	Upgrade
PB Ratio	1.01	1.12	3.59	4.77	5.63	6.25	Upgrade
P/TBV Ratio	0.76	1.12	3.59	4.77	5.63	6.25	Upgrade
EV/Sales Ratio	-	36.57	6076.87	-	57.16	-	Upgrade
Debt / Equity Ratio	0.03	0.03	0.04	0.05	0.00	0.00	Upgrade
Debt / FCF Ratio	0.20	-	-	-	-	-	Upgrade
Asset Turnover	0.37	0.01	0	-	0.08	-	Upgrade
Quick Ratio	29.02	20.56	13.63	16.92	20.96	37.04	Upgrade
Current Ratio	29.86	21.45	14.25	17.27	21.23	37.27	Upgrade
Return on Equity (ROE)	10.42%	-41.46%	-50.19%	-40.22%	-23.27%	-34.60%	Upgrade
Return on Assets (ROA)	4.40%	-26.73%	-31.39%	-25.53%	-13.43%	-20.80%	Upgrade
Return on Capital (ROIC)	4.56%	-28.12%	-33.33%	-26.82%	-13.90%	-21.65%	Upgrade
Return on Capital Employed (ROCE)	6.50%	-35.80%	-49.20%	-39.60%	-23.20%	-17.80%	Upgrade
Earnings Yield	12.10%	-29.22%	-12.84%	-7.91%	-4.29%	-2.77%	Upgrade
FCF Yield	16.35%	-25.39%	-10.66%	-5.39%	-4.61%	-2.27%	Upgrade
Buyback Yield / Dilution	-17.52%	-27.13%	-16.66%	-8.17%	-50.48%	-566.41%	Upgrade

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q